ReviewNaunyn-Schmiedeberg's archives of pharmacology2015

The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.

A Joshua Lilly et al.PubMed ↗Publisher ↗

No numbers read from the abstract.